Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Intensive Glycemic Control in Type 2 Diabetes Mellitus—A Balancing Act of Latent Benefit and Avoidable Harm
Rodríguez‐Gutiérrez, René , Lipska, Kasia J. , McCoy, Rozalina G.

JAMA Internal Medicine | February 16, 2016 | Volume: 176 | Issue: 3 | Pages: 300

10.1001/jamainternmed.2015.8320 | PMID 26882223 Get It

Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3
Fussner, Lynn A. , Hummel, Amber M., Schroeder, Darrell R. , Cartin‐Ceba, Rodrigo , Snyder, Melissa R. , Hoffman, Gary S., Kallenberg, Cees G. M., Langford, Carol A. , Seo, Philip , Clair, E. William St. , Tchao, Nadia K., Stone, John H., Silva, Francisco , Merkel, Peter A. , Monach, Paul A. , Spiera, Robert , Specks, Ulrich , Schroeder, Darrell

Arthritis & Rheumatology | February 16, 2016 | Volume: 68 | Issue: 7 | Pages: 1700-1710

10.1002/art.39637 | PMID 26882078 Get It

Objective Relapse following remission is common in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV), particularly with ANCAs directed at proteinase 3 (PR3). This study was undertaken to evaluate the association of an increase in PR3‐ANCA level with subsequent relapse. Methods Data from the Rituximab versus Cyclophosphamide for ANCA‐Associated Vasculitis (RAVE) trial were used. Starting from the time of achieving complete remission, serial measurements by direct and capture enzyme‐linked immunosorbent assays (ELISAs) were analyzed in 93 patients with PR3‐ANCA, using Cox proportional hazards regression. Results An increase in PR3‐ANCA level was identified in 58 of 93 subjects (62.4%) by direct ELISA and in 59 of 93 (63.4%) by capture ELISA. Relapses occurred in 55 of 93 subjects (59.1%), with 25 and 21 occurring within 1 year after an increase by direct ELISA and capture ELISA, respectively. An increase by direct ELISA was associated with subsequent severe relapses (hazard ratio [HR] 4.57; P < 0.001), particularly in patients presenting with renal involvement (HR 7.94; P < 0.001) and alveolar hemorrhage (HR 24.19; P < 0.001). Both assays identified increased risk for severe relapse in the rituximab group (HR 5.80; P = 0.002 for direct ELISA and HR 4.54; P = 0.007 for capture ELISA) but not the cyclophosphamide/azathioprine group ( P = 0.103 and P = 0.197, respectively). Conclusion The association of an increase in PR3‐ANCA level with the risk of subsequent relapse is partially affected by the PR3‐ANCA detection methodology, disease phenotype, and remission induction treatment. An increase in PR3‐ANCA level during complete remission conveys an increased risk of relapse, particularly severe relapse, among patients with renal involvement or alveolar hemorrhage and those treated with rituximab. Serial measurements of PR3‐ANCA may be informative in this subset of patients, but the risk of relapse must be weighed carefully against the risks associated with therapy.
Young investigator challenge: Validation and optimization of immunohistochemistry protocols for use on cellient cell block specimens
Grogg, Karen L., Vrana, Julie A. , Halvorson, Jennifer, Henry, Michael , Sauter, Jennifer L, Law, Mark E. , Halvorson, Jennifer L, Henry, Michael R, Sauter, Jennifer L. , Law, Mark E.

Cancer Cytopathology | February 16, 2016 | Volume: 124 | Issue: 2 | Pages: 89-100

10.1002/cncy.21660 | PMID 26882197 Get It

BACKGROUNDThe objective of the current study was to establish a process for validating immunohistochemistry (IHC) protocols for use on the Cellient cell block (CCB) system.METHODSThirty antibodies were initially tested on CCBs using IHC protocols previously validated on formalin‐fixed, paraffin‐embedded tissue (FFPE). Cytology samples were split to generate thrombin cell blocks (TCB) and CCBs. IHC was performed in parallel. Antibody immunoreactivity was scored, and concordance or discordance in immunoreactivity between the TCBs and CCBs for each sample was determined. Criteria for validation of an antibody were defined as concordant staining in expected positive and negative cells, in at least 5 samples each, and concordance in at least 90% of the samples total. Antibodies that failed initial validation were retested after alterations in IHC conditions.RESULTSThirteen of the 30 antibodies (43%) did not meet initial validation criteria. Of those, 8 antibodies (calretinin, clusters of differentiation [CD] 3, CD20, CDX2, cytokeratin 20, estrogen receptor, MOC‐31, and p16) were optimized for CCBs and subsequently validated. Despite several alterations in conditions, 3 antibodies (Ber‐EP4, D2‐40, and paired box gene 8 [PAX8]) were not successfully validated.CONCLUSIONSNearly one‐half of the antibodies tested in the current study failed initial validation using IHC conditions that were established in the study laboratory for FFPE material. Although some antibodies subsequently met validation criteria after optimization of conditions, a few continued to demonstrate inadequate immunoreactivity. These findings emphasize the importance of validating IHC protocols for methanol‐fixed tissue before clinical use and suggest that optimization for alcohol fixation may be needed to obtain adequate immunoreactivity on CCBs. Cancer (Cancer Cytopathol) 2016;124:89‐99. © 2016 American Cancer Society.
Peripheral (deep) but not periventricular MRI white matter hyperintensities are increased in clinical vascular dementia compared to Alzheimer's disease
Smith, Charles D. , Johnson, Eleanor S. , Jicha, Gregory A. , Schmitt, Frederick A. , Nelson, Peter T. , Kryscio, Richard J. , Murphy, Ronan, Wellnitz, Clinton V., Eldik, Linda J. Van , Jicha, Gregory A

Brain and Behavior | February 16, 2016 | Volume: 6 | Issue: 3 | Pages: No page available

10.1002/brb3.438 | PMID 26925303 Get It

AbstractBackground and purposeVascular dementia (VAD) is a complex diagnosis at times difficult to distinguish from Alzheimer's disease (AD). MRI scans often show white matter hyperintensities (WMH) in both conditions. WMH increase with age, and both VAD and AD are associated with aging, thus presenting an attribution conundrum. In this study, we sought to show whether the amount of WMH in deep white matter (dWMH), versus periventricular white matter (PVH), would aid in the distinction between VAD and AD, independent of age.MethodsBlinded semiquantitative ratings of WMH validated by objective quantitation of WMH volume from standardized MRI image acquisitions. PVH and dWMH were rated separately and independently by two different examiners using the Scheltens scale. Receiver operator characteristic (ROC) curves were generated using logistic regression to assess classification of VAD (13 patients) versus AD (129 patients). Clinical diagnoses were made in a specialty memory disorders clinic.ResultsUsing PVH rating alone, overall classification (area under the ROC curve, AUC) was 75%, due only to the difference in age between VAD and AD patients in our study and not PVH. In contrast, dWMH rating produced 86% classification accuracy with no independent contribution from age. A global Longstreth rating that combines dWMH and PVH gave an 88% AUC.ConclusionsIncreased dWMH indicate a higher likelihood of VAD versus AD. Assessment of dWMH on MRI scans using Scheltens and Longstreth scales may aid the clinician in distinguishing the two conditions.
Assessing medication role on neuropathological findings in Parkinson's disease
Hentz, Joseph G. , Beach, Thomas G. , Adler, Charles H.

Movement Disorders | February 16, 2016 | Volume: 31 | Issue: 5 | Pages: 613-614

10.1002/mds.26536 | PMID 26879513 Get It

Low Gleason Architectural Pattern in Prostate Carcinoma: A Possible Function of Nodular Stromal Hyperplasia?
Mehta, Vikas , Barkan, Güliz A. , Jiménez, Rafael E. , Paner, Gladell P.

American Journal of Clinical Pathology | February 16, 2016 | Volume: 138 | Issue: suppl_1 | Pages: A347-A347

10.1093/ajcp/138.suppl1.323 Get It

Concordance Between Anticardiolipin and Anti-B2-Glycoprotein Antibody Testing in Clinical Practice
Ettore, Michael, Murray, David , Melissa, Snyder, Adhikari, Laura

American Journal of Clinical Pathology | February 16, 2016 | Volume: 138 | Issue: suppl_1 | Pages: A258-A258

10.1093/ajcp/138.suppl1.239 Get It

Optimizing Thawed Plasma Inventories
Kuker, Kasey N., Badjie, Karafa S., Johnson, Pamela M. , Bundy, Kevin L., Buskirk, Camille M. van , Stubbs, R. James , Bundy, Kevin L.

American Journal of Clinical Pathology | February 16, 2016 | Volume: 138 | Issue: suppl_1 | Pages: A255-A255

10.1093/ajcp/138.suppl1.237 Get It

B7-H1 and B7-H3 Expression in Granulomatous Inflammation
Sheinin, Yuri, Kwon, Eugene D.

American Journal of Clinical Pathology | February 16, 2016 | Volume: 138 | Issue: suppl_1 | Pages: A236-A236

10.1093/ajcp/138.suppl1.220 Get It

Increased IgG4+ Plasma Cells in Collagenous Sprue
Schoolmeester, J. Kenneth , Wu, Tsung‐Teh, Chandan, Vishal S. , Murray, Joseph A.

American Journal of Clinical Pathology | February 16, 2016 | Volume: 138 | Issue: suppl_1 | Pages: A118-A118

10.1093/ajcp/138.suppl1.113 Get It